Clinical trial
Study to Determine the Safety of Two Applications of PEP005 Topical Gel to…
NCT00108121 · Peplin, Industry · Completed
Key facts
| NCT number | NCT00108121 |
|---|---|
| Title | Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell Carcinoma |
| Official title | A Multi-center, Randomized, Double-blind, Parallel-group, Vehicle-controlled Study to Determine the Safety of PEP005 0.0025%, 0.01% and 0.05% Gel With Two Treatment Schedules, Day 1 & 2 or Day 1 & 8 Applications to Nodular Basal Cell Carcinoma |
| Lead sponsor | Peplin, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Basal Cell Carcinoma |
| Intervention type | Drug |
| Interventions | PEP005 |
| Enrollment | 60 |
| Start date | Mar 1, 2005 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Apr 15, 2005 |
| Last update posted | Jan 19, 2015 |
| Countries | Australia |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: